Aerobic Exercise Versus Digital Cognitive Behavioral Therapy for Insomnia
Effects of Aerobic Exercise Versus Digital Cognitive Behavioral Therapy for Insomnia in University Students With Insomnia Complaints
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Giselle Soares Passos, PhD
- Phone Number: +55 064 981036150
- Email: passos.gs@gmail.com
Study Locations
-
-
Goiás
-
Jatai, Goiás, Brazil, 75801-615
- Recruiting
- Maria Tereza
-
Contact:
- Maria Tereza Vidigal, Master Degree Student
- Phone Number: +55 64 992220588
- Email: mariatereza.vidigal@gmail.com
-
Contact:
- Renata Bolzan (Graduate Student)
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ages ≥ 18 years old
- insomnia severity index score >8
- be physically inactive according to the IPAQ questionnaire
Exclusion criteria:
- non-adherence to intervention protocols
- absence or incomplete answers in the questionnaires/evaluation methods of the study
- shift workers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Aerobic Exercise
Three sessions of aerobic exercise per week (outdoor walking), for 50 continuous minutes, at moderate intensity (Identified by the Borg Subjective Perception of Exertion Scale, scores from 12 to 13), will be performed for 7 weeks.
These sessions will be accompanied by a researcher responsible for data collection, who will make a daily record of the activities.
The practice time will be between 5:00 pm and 7:00 pm.
|
50 continuous minutes, at moderate intensity (Identified by the Borg Subjective Perception of Exertion Scale, scores from 12 to 13)
|
|
Active Comparator: Digital Cognitive Behavioral Therapy (CBT-I)
Three weekly sessions of digital CBT-I will be held through the Vigilantes do Sono® application (digital therapy with the therapeutic protocol approved by ANVISA, Brazil).
|
CBT-I includes some therapies, including sleep restriction therapy, stimulus control therapy, sleep hygiene education, relaxation and cognitive therapy[19].
Traditionally, CBT-I is applied in person (individually or in a group) by a trained psychologist or psychiatrist.
However, several studies show similar effects when CBT-I is performed remotely, and online (digital)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia Severity
Time Frame: baseline and post-intervention (7 weeks)
|
The severity of insomnia will be assessed using the Insomnia Severity Index (ISI) questionnaire.
This instrument was developed to assess insomnia complaints.
It is a self-administering, brief and simple scale, composed of 7 items that can be classified from 0 to 4, with the lowest final score = 0 and the highest = 28.
Scores from 0 to 7 are considered non-significant insomnia, lower limit for insomnia from 8 to 14, moderate insomnia from 15 to 21, and severe insomnia from 22 to 28
|
baseline and post-intervention (7 weeks)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical evaluation and Anamnesis
Time Frame: baseline and post-intervention (7 weeks)
|
To evaluate the changes in the body composition (body mass, % fat and fat-free mass) of participants, a bioimpedance scale (Omron, HBF-514) will be used, with a capacity of up to 150kg.
Height will be assessed by stadiometer (Sanny, Professional).
The Body Mass Index (body mass/height 2) will be calculated.
An anamnesis form will be used to record the participants' personal information such as age, gender, use of medications, etc
|
baseline and post-intervention (7 weeks)
|
|
Cognitive and somatic arousal
Time Frame: baseline and post-intervention (7 weeks)
|
To assess the level of pre-sleep cognitive and somatic arousal, the self-reported questionnaire will be used Pre-Sleep Arousal Scale (PSAS), composed of 16 items, 8 of which assess cognitive alertness and 8 assess somatic alertness.
Each item has a 5-point scale that determines the intensity of the symptom experienced at the onset of sleep, with a score of 1 being no symptoms experienced and a score of 5 expressing an extremely intense symptom.
|
baseline and post-intervention (7 weeks)
|
|
Sleep Quality
Time Frame: baseline and post-intervention (7 weeks)
|
The Pittsburgh Sleep Quality Index (PSQI) will be used to assess the sleep quality over the past 30 days.
An overall score of 5 or less indicates good sleep quality, whereas scores greater than 5 indicate poor sleep quality.
|
baseline and post-intervention (7 weeks)
|
|
Sleep Diary
Time Frame: baseline and post-intervention (7 weeks)
|
The sleep diary is a method used to assess the subjective perception of sleep quality, so it should be answered in the morning upon waking.
The questions contained in this questionnaire are related to bedtime and wake-up times, the number of hours of sleep, latency to sleep onset, and awakenings during the night.
|
baseline and post-intervention (7 weeks)
|
|
Symptoms of anxiety, depression, and stress
Time Frame: baseline and post-intervention (7 weeks)
|
Depression Anxiety Stress Scale-21 (DASS-21) will be used to evaluate anxiety, depression and stress.
It is an instrument composed of a self-report scale that contains a set of three subscales type Likert of four points 0, 1, 2 and 3, where zero (strongly disagree) and three (strongly agree).
Each subscale of the DASS-21 It consists of seven items.
The variations in the scores correspond to the severity of the symptoms for each subscale, which vary between "normal", "minimal", "mild", "moderate", "severe and "very severe".
The scores of each subscale were calculated by summing the scores of the seven items, multiplied by two.
|
baseline and post-intervention (7 weeks)
|
|
Physical activity level
Time Frame: baseline and post-intervention (7 weeks)
|
The short version of the International Physical Activity Questionnaire (IPAQ-SF) will be used to assess the level of physical activity of the participants, with reference to the activities of the last week.
The questionnaire consists of questions regarding the frequency and duration of moderate, vigorous, and walking physical activities.
Participants will be classified as insufficiently active (<150 minutes of moderate activity/week) and active (≥150 minutes of moderate activity).
|
baseline and post-intervention (7 weeks)
|
|
Sedentary Behavior
Time Frame: baseline and post-intervention (7 weeks)
|
Sedentary behavior will be assessed using time spent sitting during a typical weekday and weekend.
The following equation will be applied to calculate the average sitting time per day: [(week x 5) + (weekend x 2)] / 7. Daily sitting time classified into 3 categories (<8 hours per day, ≥ 8 to < 11 hours a day and ≥ 11 hours a day).
|
baseline and post-intervention (7 weeks)
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Vignola RC, Tucci AM. Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese. J Affect Disord. 2014 Feb;155:104-9. doi: 10.1016/j.jad.2013.10.031. Epub 2013 Oct 28.
- Rosenberg DE, Bull FC, Marshall AL, Sallis JF, Bauman AE. Assessment of sedentary behavior with the International Physical Activity Questionnaire. J Phys Act Health. 2008;5 Suppl 1:S30-44. doi: 10.1123/jpah.5.s1.s30.
- Matsudo, S., Araújo, T., Matsudo, V., Andrade, D., Andrade, E., Oliveira, L. C., Braggion, G. International Physical Activity Questionnaire (IPAQ): Validity and reproducibility study in Brazil. . Brazilian Journal of Physical Activity and Health. 2001,5:5-18.
- Ruivo Marques D, Allen Gomes A, Nicassio PM, Azevedo MHP. Pre-Sleep Arousal Scale (PSAS): psychometric study of a European Portuguese version. Sleep Med. 2018 Mar;43:60-65. doi: 10.1016/j.sleep.2017.10.014. Epub 2017 Dec 19.
- Bertolazi AN, Fagondes SC, Hoff LS, Dartora EG, Miozzo IC, de Barba ME, Barreto SS. Validation of the Brazilian Portuguese version of the Pittsburgh Sleep Quality Index. Sleep Med. 2011 Jan;12(1):70-5. doi: 10.1016/j.sleep.2010.04.020. Epub 2010 Dec 9.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Mental Disorders
- Behavioral Symptoms
- Sleep Wake Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Behavior
- Anxiety Disorders
- Depression
- Sleep Initiation and Maintenance Disorders
- Motor Activity
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Behavior Therapy
- Psychotherapy
- Behavioral Disciplines and Activities
- Exercise
- Cognitive Behavioral Therapy
Other Study ID Numbers
Other Study ID Numbers
- PI05992-2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.